Clinical trial
Smartphone-based Digital Phenotyping to Detect High-risk Affect States in Body Dysmorphic Disorder (BDD)
NCT04254575 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Smartphone-based Digital Phenotyping to Detect High-risk Affect States in Body Dysmorphic Disorder (BDD)
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 15, 2020
- Completion date
- April 28, 2023
- Enrollment
- 87 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.